Upload
sofie-staelraeve
View
108
Download
7
Embed Size (px)
Citation preview
2
03
05
06
29
33
35
36
37
42
Foreword
Highlights 2016
European HealthTech Scaleups
Methodology
About the authors
About Sirris
About dashplus
Data sources
Disclaimer
TABLE OF CONTENTS
3
2016 EUROPEAN HEALTHTECH REPORT FOREWORD
PARTNERS
HealthTech is at the forefront of startups and scaleups, in the United
States as well as in Europe. There is no single European healthcare
system or market. Instead, high complexity and cultural diversity of
healthcare systems makes it challenging to jump into multiple markets
and thus to scaleup new companies. But if you take a close look, you’ll
quickly notice that there is interesting stuff happening in Europe
With this report we want to provide a comprehensive review of
investment in startups and high-growth HealthTech technology
companies across 31 countries in Europe. Our aim is to provide data-
driven guidance, insights, perspective and inspiration to stakeholders in
the European scaleup ecosystem.
We hope you find the 2016 edition of the report informative.
Sincerely,
Omar Mohout & Sofie Staelraeve
4
This report is part of a series of funding
reports, published both quarterly and yearly.
Other reports complement the series,
focusing on geographical markets and vertical
industries such as the HealthTech report,
written in collaboration with dashplus or the
FinTech report in collaboration with
Eggsplore.
2016 EUROPEAN HEALTHTECH REPORT ABOUT
This report is a snapshot in time, aimed at
analysing funding data, major trends within
the industry and the regions.
Only deals of at least $1M / € 750K are
considered for this report.
If you would like to provide your input for the
report, signal an omission of data or have any
other feedback, we would love to hear it. Just
pop an email to [email protected] and
ABOUT THIS REPORT
HIGHLIGHTS 2016
5
• € 1.1B across 148 deals in 31 countries;
• UK is leading both in funding and in number of deals;
• The city with the highest number of deals is London, followed by
Paris and Stockholm;
• Bpifrance is the most active EU venture fund in Europe;
• Hardware is the most popular business model and technology used
by European HealthTech scaleups;
• HealthTech is the second most funded industry in number of deals;
• 4 European HealthTech companies went IPO raising € 102M;
• 64% of European HealthTech scaleups are B2B oriented;
• 4 HealthTech companies raised twice capital in the same year: Min
Doktor, Coala Life, Brainshake & Sonitor Technologies. Remarkable,
all 4 are from the Nordics.
2016 EUROPEAN HEALTHTECH REPORT HIGHLIGHTS
7
€ 286
€ 174
€ 120
€ 110
€ 91
€ 54
€ 50
€ 40
€ 37
€ 33
€ 21
€ 20
€ 18
€ 14
€ 7
€ 7
€ 1
UK
Switzerland
France
Sweden
Ireland
Germany
Belgium
Serbia
Spain
Netherlands
Norway
Italy
Poland
Finland
Denmark
Austria
Hungary
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
AMOUNT RAISED PER COUNTRY 2016*
*In millions
UK is leading, both in funding andin number of HealthTech deals in2016. Switzerland is second best interms of amount of capital raised.
The gap between France/UK andGermany is significant. While tinySweden is performing in the sameleague as the biggest economy ofEurope, almost hitting France.
Other smaller countries such asIreland and Belgium are doing welland are punching above theireconomic weight.
8
32
26
18
11
10
8
7
6
6
6
6
4
4
1
1
1
1
UK
France
Sweden
Belgium
Germany
Switzerland
Netherlands
Finland
Ireland
Spain
Italy
Norway
Denmark
Serbia
Hungary
Poland
Austria
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
UK and France are leading. Sweden and
Belgium are taking a very interesting 3rd and
4th position. No doubt Sweden is the rising
star in Health, leaving Germany and
Switzerland behind in amount of deals in
2016.
Belgium is doing great. It seems like public
agenda setting for digital transformation and
creation of a start-up ecosystem are paying
off..
Germany has HealthTech scaling up growth
potential. Compared to its other sectors,
HealthTech investments are lagging behind.
DEALS PER COUNTRY 2016
9
€ 54
€ 137
€ 80
€ 120
€ 87 € 82
€ 105
€ 33
€ 66 € 56
€ 93
€ 170
Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec.
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
CAPITAL RAISED 2016*
*In millions
European HealthTech scaleupstogether raise in average € 90million per month.
The highest peak In December isdue to Oxford NanoporeTechnologies raising € 119 million.The company tries to establish theconcept of an “Internet of Livingthings”.
2 companies (HealthUnlocked,Infinity Health) used crowdfundingto raise growth capital.
10
1312
9
13 13
16
14
1011
10
17
11
Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec.
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
In average 12 HealthTech deals of atleast € 750K are closed in Europeevery month.
NUMBER OF DEALS 2016
11
47%
24%
14%
5%
3%
2%
1%
1%
1%
1%
1%
Series A
Seed
Series B
Series C
IPO
Crowdfunding
Series G
Grant
Post IPO Equity
Convertible Note
Debt financing
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Given the threshold of € 750K/$1M, it’s not surprising that themajority of deals are series A.
Convertible notes are less popularin Europe and count for only 1%.
DEAL TYPE 2016
12
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
AVERAGE FOUNDING YEAR
Finland
Germany
Switzerland
2010
Sweden
Spain
France
UK
Netherlands
Ireland
2011
Denmark
Italy
2012
Belgium
2013
To raise a series A in Europe, acompany needs to be founded in2011.
It takes in average 5 (long!) yearsfor HealthTech companies to raisesubstantial external financing.
Austria
2014
13
31
30
30
30
30
27
25
25
25
19
16
16
14
UK
Ireland
Norway
Switzerland
Spain
Hungary
Germany
France
Denmark
Sweden
Belgium
Austria
Finland
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
The number of employees iscaptured on the moment of fundraising and based on the pressrelease, LinkedIn, Xing, Viadeo orthe company’s website.
On average, HealthTech scaleupshave 30 employees. Swedish andBelgian scale-ups have rather fewemployees. Norwegian andSpanish companies hire morepeople.
AVERAGE NUMBER OF EMPLOYEES PER COMPANY 2016
1. London
2. Paris
3. Stockholm
4. Cambridge
5. Lausanne
6. Ghent
7. Barcelona
8. Oslo
9. Berlin
10. Dublin
1. Lausanne
2. Oxford
3. Stockholm
4. London
5. Paris
6. Blackrock
7. Belgrade
8. Dublin
9. Cambridge
10. Geneva
14
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
HEALTHTECH CITIES 2016
NUMBER OF DEALS AMOUNT RAISED London counts for 41% of all UKdeals, Paris for 46%, Berlin for 34%and Stockholm for 56%.
Barcelona, Ghent and Lausanne arethe scaleup cities of their respectivecountry instead of the capital cities.
Note how the UK is the onlycountry that has 3 cities (London,Cambridge and Oxford) in the list.
3 out of 5 Lausanne scale-ups raisedmore than € 10 million.
15
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
We have split HealthTech into 4 subcategories:
1. MedTech (typical being used bymedical professionals and oftenrequires connected hardware);
2. CareTech (typical support thehealthcare process such asbooking platforms);
3. HealthTech itself (typicallybeing used by the patientdirectly) and;
4. Lifescience (digital solutionused by or for the life scienceindustry).
BREAKDOWN OF THE INDUSTRY
CareTech37%
HealthTech31%
Lifescience7%
MedTech25%
64%
36%
B2B B2C
78%
22%
B2B B2C
16
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
B2B & B2C COMPARISON
NUMBEROF DEALS
AMOUNTRAISED
European HealthTech is predominantlyB2B. In general 64% of all scale-ups areB2B, that is some 6% more than theoverall scale-up ecosystem.
B2C companies sign up for more deals,earlier after founding. But in general,they raise smaller amounts of capital.Top 10 of amount raised includes only2 B2C companies: Frisq (Stockholm)and Clue (Berlin).
Paris, London (UK), and Stockholm arethe places to be for B2C HealthTechscaleups. Cambridge (UK), Switzerlandand Ireland dominate B2B HealthTechdeals.
British Nanopore (B2B) and SwedishFrisk (B2C) raised the largest amountof money.
17
100% 100%
88%
80% 80%
73%69% 67%
60%
50% 50%
33% 33%
0% 0%
13%
20% 20%
27%31% 33%
40%
50% 50%
67% 67%
Ireland Netherlands Switzerland Finland Norway Belgium UK Italy Germany Denmark France Spain Sweden
B2B
B2C
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
B2B & B2C NUMBER OF DEALS PER COUNTRY
Top 13 countries
18
34%
16%
8%
8%
6%
5%
4%
4%
3%
3%
2%
2%
Hardware
Marketplace
Wearable
Artificial Intelligence
Data Analytics
SaaS
App
Internet of Things
Video driven
Robotics
Virtual Reality
3D printing
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Not surprisingly, hardware,traditionally very strong in theengineering cultures of Europeancountries, is the leading businessmodel for scaleups, counting for34% of the total.
France is leading in hardware andIoT while market places, robotics,video and apps is dominated by theUK. Sweden is the #1 spot forwearables and SaaS; Switzerland for3D printing and video; Finland fordata analytics, and Belgium for AI.
TYPE OF BUSINESS MODELS/TECHNOLOGY 2016
19
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
TOP 5 BIGGEST DEALS*
€ 119M € 89M € 39M€ 40M € 30M#01 #02 #03 #04 #05
*In amount raised
20
21%
17%
12%
10%
10%
7%
7%
5%
5%
2%
2%
2%
UK
Belgium
France
Netherlands
Italy
Switzerland
Germany
Norway
Sweden
Denmark
Hungary
Ireland
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
28% of European HealthTechscaleups are spin-offs or spin-outsfrom universities and knowledgeinstitutes.
Compared to only 8% of thescaleups across all industries, itindicates that the HealthTechecosystem is strongly driven by IPthat is generated in an academicenvironment.
SPIN-OFFS BY COUNTRY 2016
21
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Note the extremely highperformance of Belgium claimingmore than half of the top positions,a testimony to the vibrantecosystem going back to its longBioTech history.
MOST ACTIVE SPIN-OFF INSTITUTES 2016
1. University of Cambridge (UK)
2. imec (Belgium)
3. University of Ghent (Belgium)
4. KULeuven (Belgium)
5. Inserm (France)
6. École Polytechnique Fédérale de Lausanne (Switzerland)
22
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
11% of the European HealthTechscaleups graduated from anacceleration program. That’s lessthan the 14% across all industries.
Program alumni don’t necessaryraise more money, but they are 1.5years younger on average when theyraise money. It might well be thatthey can start to scale earlier orhave better access to investorsthanks to acceleration programs.
ACCELERATORS, BY NUMBER OF FUNDED SCALEUPS 2016
1. imec.istart (Belgium)
2. StartUp Health (Finland)
3. Seedcamp (UK)
4. Y Combinator (US)
5. thinkubator (Denmark)
6. LeanSquare (Belgium)
7. Founders Factory (UK)
8. Accelerator London (UK)
9. Axel Springer Plug and Play (Germany)
10. StartupLab (Norway)
11. THINGS (Sweden)
12. Welcome City Lab (France)
13. M31 (Italy)
14. Project A Ventures (Germany)
15. Paris&Co (France)
23
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Corporate Venture Capital isinvolved in 14% of all Europeandeals and 18% of all capital raised.This is similar to other industries.
The highest corporate investmentwas € 89M in Swiss MindMaze byHinduja Group, an Indianconglomerate company that isheadquartered in London.
CORPORATE VENTURE CAPITAL INVESTORS 2016
ABB, Alex Springer, AXA, Bauer Media Group, Bonnier,Cnp Assurances, Fig, Furui Science, Henderson LandDevelopment Company, Hinduja Group, Innocentdrinks, Kaiser Permanente, Medtronic, Müller MedienGroup, Nokia, NovioTech, ProSiebenSat.1, Puhua JingxinGuzhou Health, Samsung, Seb, Swisscom, Telefónica,Tokai Optecs, TQ-Group, Unilever, ZürcherKantonalbank
24
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
The most active 2016 venture investor in
Europe for HealthTech are the French and
German government.
Contrary to other industries, investors in
HealthTech companies are European, not
from the US. We believe that one of the
reasons is that HealthTech is often subject to
a number of regulation constraints and are
heavily depending on national healthcare
systems making it harder for VCs to assess
the global potential.
More than 350 funds and business angels
made investments in HealthTech scaleups.
MOST ACTIVE INVESTORS
Bpifrance1. (France)
High2. -Tech Gründerfonds (Germany)
Parkwalk3. Advisors (UK)
Bayern4. Kapital (Germany)
Capricorn5. Venture Partners (Belgium)
QBIC6. (Belgium)
Gilde7. Healthcare (Netherlands)
8. IQ Capital (UK)
Amadeus9. Capital Partners (UK)
Draper10. Esprit (UK)
25
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Europe saw four IPOs ofHealthTech companies in 2016totalling € 102M.
2 IPOs are from Swedishcompanies. Sweden also saw theyoungest company going public,Cellink founded in 2016.
Mainstay Medical, a public companyfrom Ireland, raised € 30M in post-IPO equity from KCK. So did FrenchTheraclion from Furui Science Co.
IPO 2016
Cellink1. (Sweden, Nasdaq First North)
Frisq2. (Sweden, Nasdaq First North)
Creo3. Medical (UK, AIM)
Oneview4. Healthcare (Ireland, Australian Securities Exchange)
ADDITIONAL HIGHLIGHTS 2016
26
Cellink• , a Swedish 3D bioprinter company; is been established in January
2016 and went public 10 months later raising € 15M on Nasdaq First North;
Swedish• Diasend, merged with Mountain View based Glooko into a unified
company to create a leading diabetes management platform;
• 4 HealthTech companies raised twice capital in the same year: Min Doktor,
Coala Life, Brainshake & Sonitor Technologies. Remarkable, all 4 are from
the Nordics;
Belgian• based Indigo Diabetes raised capital from the highest number of
investors: Thuja Capital, PMV, Sensinnovat, Parana Management Corp, Qbic,
Fidimec, SOFI, Manuardeo and Capricorn Venture Partners;
• Irish SiriusXT, a spin-off from University College Dublin, received a € 3M
grant from the European Commission;
• 8 HealthTech scaleups have more than 100 employees (Seven Bridges,
Oxford Nanopore Technologies, Babylon Health, MonDocteur, T&J
Healthcare, DocPlanner, Oneview Healthcare & SpineArt);
• The oldest HealthTech company to receive growth capital is French Biolog-
ID, founded in 1981;
• 4 companies that are launched in 2016 received significant funding: Indigo
Diabetes (Belgium), Eyeco Eyeco (Belgium), Cera (UK) & Cellink (Sweden);
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
HEALTHTECH SCALEUPS WITH REMARKABLE BUSINESS MODELS
OR TECHNOLOGY
27
French• Nino Robotics: The personal transponder (wheelchair) of
the new century;
Belgian• Eyeco Eyeco: Introducing digital lenses with an
uncompromising field of view, all the time;
French• H4D: The Consult Stations are autonomous medical units
replicating a medical doctor’s office;
• Danish AthGene: subscription-based genetics platform;
• Swedish Werlabs: a user picks up on the web shop what blood
tests he or she wants to get done, pays the test online – and the
next day one can head to take the test at both public and private
clinics;
• UK based MedShr and HealthUnlocked: both companies have a
business model based on a community. For MedShr it’s for medical
professionals and HealthUnlocked is for sufferers of Lupus.
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
EUROPEAN
VENTURE CAPITAL
2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
Click on the above link to access the full dataset
28
30
Scaleups, not startups, are generating added value,
create jobs, expand international and create economic
value for stakeholders and society. This group is
attracting the lion share of (venture) capital, in some
countries of up to 90% of all capital. In other words, we
use the Pareto distribution rule to create an accurate
view on the venturing landscape. Only deals of at least
$1M / € 750K are considered.
We encourage you to review the methodology to betterunderstand the numbers presented in this report. We usea data-driven approach to track financing activity forEuropean tech companies.
Companies includes web, app, mobile, digital productsand services, software, marketplace, connectedhardware, data-driven and HardTech companies.Companies that have their HQ or launched in Europe areconsidered. LifeScience and BioTech (except softwaresolutions targeting this industry), non digital CleanTech,eCommerce (Hallofresh, Zalando etc) and researchinstitutes are excluded.
2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
31
Deals with a non-disclosed value or lacking value indication are not counted. If an amount is
described as a seven-figure number, the lowest possible value has been counted. Funding is
registered based on announcement date. All currencies (USD, GBP, CHF, SEK etc) are converted to
Euro using aonda.com. The number of employees is captured on the moment of fund raising and
based on the press release, LinkedIn, Xing, Viadeo or the company’s website.
The founding year and location is based on information in press releases, company website,
Crunchbase, LinkedIn or Xing. If deal information is being detected or corrected after closing the
month, quarter or year, it will be included in future reports. Funding of both private and public
companies are considered. Debt financing, IPOs, media for equity, crowdfunding, Initial Coin
Offering, private placements, post IPO equity, private equity, grants and convertible loans are
included.
2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
32
THE CATEGORIES ARE:
HealthTech, CareTech, MedTech and Lifescience
THE COUNTRIES ARE:
Albania, Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France,
Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Netherlands,
Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland and
UK. Data of Turkey and Israel is being used as a benchmark for Europe.
2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
33
Omar Mohout is a former technology entrepreneur currently active as Growth Engineer at Sirris.
Mohout is a widely published technology author, C-level advisor to high growth startups as well
as Fortune 500 companies and Professor of Entrepreneurship at Antwerp Management School.
He is author of 'Pricing Strategies for Startups', ‘The Belgian startup landscape’, ‘Crowdfunding in
Belgium’ and the popular 'Startup Master Class series'. A contributing author to the ‘100 Days
Digital Marketing Plan’ and ‘The Future of Business’ books.
Mohout is a columnist; Co-chair of the Circle Of Growth, Organizer of the Growth Hacking
Meetup, Co-founder of the #BeTech Community and Member of the Board of Directors at
Startups.be, Teamleader and Aproplan. He is also a mentor at Founder Institute, IdeaLabs,
Startathlon, Virtuology Academy, Nexxworks and Belgium Ambassador at World Startup Report.
Mohout is a keynote speaker and panellist on technology, entrepreneurship and innovation
topics at leading conferences.
2016 EUROPEAN HEALTHTECH REPORT ABOUT THE AUTHOR
OMAR MOHOUT
34
Sofie is founder of dash_+, helping new health entrepreneurs and giving them the right fuel to
shift to value-based health. Dash_+ focusses on partnerships, go to market and innovation
strategy for new health companies and organisations. Sofie holds a Phd in Political Sciences. She
specialised in public policy and innovation in periods of crisis and disruption. She worked in
public, research and private environments. As a co-founder and director of the Voka Health
Community in Belgium, she worked extensively with Belgian companies, health organisations,
researchers and patient groups.
Staelraeve is a member of the Belgian e-health platform, member of the board of Howest
university college and member of the board of Syntra Vlaanderen.
Sofie is author of several vision papers on the future of health. Together with Omar Mohout , she
published ‘5 things you should know about Belgian HealthTech in 2017’.
2016 EUROPEAN HEALTHTECH REPORT ABOUT THE AUTHOR
SOFIE STAELRAEVE
35
Sirris, the collective centre of the Belgian technology industry, helps companies with the
implementation of technological innovations, enabling them to strengthen their competitive
position over the long-term. Sirris helps you make the best technological choice and rapidly turn
your innovations into marketable products and services. The Sirris experts visit companies on
site, offer technological advice, launch innovation paths, and provide guidance to reach the
implementation phase. The aim is to find applicable solutions to the real challenges faced by
technology entrepreneurs and startups.
Sirris guides technology companies to a higher level of know-how and expertise in a wide range
of domains. The in-house experts provide a broad range of technological and go-to-market
knowledge. Where necessary, Sirris relies also on external knowledge partners, including
specialized companies, universities, knowledge centres, and research institutions.
For more information on how Sirris can help your company success, please visit www.sirris.be.
2016 EUROPEAN HEALTHTECH REPORT ABOUT SIRRIS
36
2016 EUROPEAN HEALTHTECH REPORT ABOUT SIRRIS
Dash_+ is your fast lane to new health entrepreneurship. We help health entrepreneurs all over
Europe to define and implement their innovation strategy, to find and cooperate with new
partners, and to accelerate their go to market.
Our mission is to create integrated health companies: high value, innovative health companies
and organizations, working together all along the value chain to create value based, sustainable
healthcare.
We work for (international) start ups, scale ups, big companies, care organisations, and public
stakeholders.
For more information on how dash_+ can help your company success, please visit dashplus.be.
37
2016 EUROPEAN HEALTHTECH REPORT SOURCES
SPECIAL THANKS
Serkan Ünsal, startups.watch for covering Turkey and Tech.eu for the most detailed coverage of Europe
WEBSITES & NEWSLETTERS
150sec, agfundernews.com, allbrain.org, alliancy.fr, alloweb.org, angellist, arcticstartup, avoltapartners, barcinno, beauhurst, breakit.se, businessinsider.com,
calaofinance.com, cbinsights, cityam.com, cmuportugal.org, coindesk, companisto.com, computable.nl, computable.be, datafox, datanews.be, dealroom, derbrutkasten,
deutsche-startups.de, digital.di.se, dn.no, dublinglobe.com, e52.nl, economyup.it, emeastartups.com, enterprise.cam.ac.uk, eu-startups, finanznachrichten.de, finsmes,
fora.ie, frenchweb.fr, funderbeam.com, geektime.com, gigaom.com, GIMV, globalcorporateventuring.com, noah conference, go4venture.com, goaleurope.com,
goodnewsfinland.com, gruenderszene.de, high-tech-gruenderfonds.de, ideaspace.cam.ac.uk, Index.co, itespresso.fr, ivca.ie, ivc-online.com, journaldunet.com, jvpvc.com,
labsoflatvia.com, lesechos.fr, lightwaveonline, linkis.com, loogic, maddyness.com, marketwatch, mattermark, myfrenchstartup.com, nocamels.com, nordurskautid.is,
oresundstartups.com, palico.com, Pando.com, parisandco.com, parkwalkadvisors.com, pehub, pitchbook, portugalstartups.com, prnewswire, regional-it.be,
rudebaguette.com, scotsman.com, seedrs.com, shifter.no, siliconcanals, siliconrepublic.com, spotfolio.com, sprout.nl, startablish.at, startupitalia.eu, startupjuncture,
startups.be, startups.co.uk, startups.watch, startupticker, swedishstartupspace.com, syncni.com, syndicateroom.com, tech.eu, techberlin.com, techcitynews,
techCrunch.com, techsite.io, theheureka.com, thetechportal.com, toftecompany.com, trendingtopics.at, trendsonline.dk, unquote, usine-digitale, vc-europe, wall-street.ro,
webcapitalriesgo.com, webrazzi, websummit, widoobiz
SOCIAL MEDIA
Abyssinia, amaigre, atizo, AudingaJa, AudingaJar, austrianstartup, Barcinno, BeTech_, blpoland, boostturku, bot_innovation, Brainport_regio, breakit_se,
BridgeBudapest, cdixon, chrysalisleap, chulu, ClujHub, CowboyGamedevBt, cphftw, csdeptucy, CyprusInno, davidcohen, Digital_Magics, dinaistwitting, DStartups,
dublin_startups, dziennik, El_Startupero, Emerce, EndeavorGr, ericries, etohum, festivaluprise, frontiersci, goodnewsfinland, growthfunders, gruenderszene,
health_xl, HelloPirates, hightechcampus, how_to_web, HUB13_Helsinki, hubvilnius, ICTSpring, ID_GC, ImpactHubBA, ImpactHubRO, impacthubzurich, ineshaeufler,
InkubatorStart, inkubatorypl, Innovaspain, InnovAthens, InternetWeekLJ, istanbulstartup, iTXFROM, joonathan, JouveSud, Kbinkubators, KBinkubators, keskkyla,
38
2016 EUROPEAN HEALTHTECH REPORT SOURCES
SOCIAL MEDIA (CONT.)
labsoflatvia, LAUNCHub, Leapfunder, LeumiTech, LisbonChallenge, LOFFICEbudapest, louishavri, LuceyFund, Lupacz, MadeinJLM, marketerslu, MassChallengeUK,
masteringrowth, metavallon, miniforetak, MMKlaszter, MusicHackFest, NCBR_pl, nestholma, NeulogyVC, NewTrendBG, NoCamels, NorthstarVent, OsloInnoEmbassy,
placeprint_mktg, ppmessengerpp, ProgramaMinerva, pt_startups, rp_teknoloji, Rubixlab, sama, saminnovatorene, sbcCopenhagen, SDigestCork, SeedstarsWorld,
sektorfuenf, SICampNorway, SiliconLux, siliconvikings, SkatteFUNN, Smart_Ireland, SmartCity4Italy, socialbakers, sprout_nl, STAkrog, StarCubeCZ, startitup_sk,
startup_italia, Startup_Kingdom, Startup_Podcast, StartUpBraga, startupbrett, StartupCampSK, startupestonia, startupgrind_LU, startupiceland, startupireland,
startupjobsite, STARTUPLISBOA, StartupRVK, StartupsBe, startupturkey, startupvcnews, startupyard, StartUscc, stefanlundell, STHLMTech, summitdesignatx,
swluxembourg, SwPrivateequity, Tech_Acad_Fin, tech_eu, TechBritannia, TechHubBuc, TechHubRiga, Technoport_, thecoulroom, thinkubator_dk, timwcap,
tyinternety, VC_watcher, venturelab_ch, version2dk, Vienna_CM, VirginStartUp, webcampzg, webrazzi, whiteboardmag, WHMeanor, ZIPZg, KairosSocietyHU,
SitraFund, ForumVirium, Tech_Acad_Fin, ReloadGreece, colabathens, bitspiration, NCBR_pl, blpoland, dziennik, CyberparkTGB, rp_teknoloji, sosyalmedyaco, IATurkije,
czechcrunch, PerpetuumZg, helgosson, StartupGrindSWE, ZuoraEMEA, nyteknik, CampusLondon, growthfunders, VirginStartUp, MassChallengeUK, CognicityCW, INiTS_at,
austrianstartup, IPNunes, SDigestCork, RyanAcademy, , LuceyFund, CrowdfundSpirit, kurtfinance, JouveSud, FuenteLatina, Silicon_wadi, BuildStuffLT, hightechcampus,
HollandFinTech, Leapfunder, IMPACT_acc, ProgramaMinerva, playinglean, , Teknisk, NorskVenture, StartupLabNo, rp_teknoloji, sosyalmedyaco, sbcIstanbul,
DLDConference, VC_watcher, startupradioDE, HTGF_, Lupacz, tyinternety, EconomyUp, SmartCity4Italy, Puglia_Startup, how_to_web, SeedstarsWorld, JeanneMazuret,
ParkwalkAdvisor
39
2016 EUROPEAN HEALTHTECH REPORT INVESTORS
20 North Street ,24Haymarket ,500 Startups ,5Lion Holdings ,7NXT ,A Plus Finance ,ABB Technology Ventures ,Ackermans & van Haaren ,Act One Ventures ,Adam Balon
,Adriaan Hart de Ruijter ,Advanced Manufacturing Supply Chain Initiative ,AIM ,Alec Behrens ,Alex Norström ,Alter Equity 3P ,Amadeus Capital Partners ,Anders Nyrén ,Angel
CoFund ,Annie Vereecken ,Apposite Capital ,Aqui invest ,Aquitaine Limousin Poitou-Charentes ,Archangel Informal Investments ,Arnie Sriskandarajah ,Atlante Ventures
,Audacia ,Australian Securities Exchange ,AXA Strategic Ventures ,Axel Springer Plug and Play ,Axis ,Banexi Ventures ,Bauer Media Group ,Bayern Kapital ,BB Biotech
Ventures ,BGF Ventures ,BioMedPartners ,Biover II ,Blue Ocean Ventures ,BNP Paribas Développement ,BNP Paribas Fortis ,Boehringer Ingelheim Venture Fund ,Bonnier
,Bonsai ,Bpifrance ,Brabant Development Agency ,Brigitte Mohn ,Broadview Ventures ,b-to-v Partners ,Cabiedes & Partners ,Caixa Capital Risc ,Cambridge Angels ,Cambridge
Capital Group ,Cambridge Enterprise ,Cambridge Innovation Capital ,Canaan Partners ,Cap Horn Invest ,Capricorn Venture Partners ,CBC Holdings ,CEA ,CEA Investissement
,Christian W. Jansson ,Christophe Maire ,Cita Investissement ,Cnp Assurances ,Cor Group ,CPH ,Creandum ,Credo Ventures ,Crowdcube ,Daniel Ek ,David Buttress ,DBH
Investment ,Demis Hassabis ,Downing Ventures ,Draper Esprit ,EBRD ,Efficient Capacity ,Egil Myklebust. ,EMESA ,ENERN Investments ,Enterprise Ireland ,EQT Ventures
,Esther Dyson ,European Commission ,Eventures ,F3F ,Faraday Venture Partners ,Fidimec ,Fig ,Filip Engelbert ,Finnvera ,Finovam ,FJ Labs ,Fondazione Cottino ,Forrestal
Capital ,Forward Partners ,Founders Fund ,Fraunhofer Venture ,Furui Science Co ,Galia Gestion ,Gary Lin ,Gemma Frisius Fund ,Gilde Healthcare ,GIMV ,Giving Wings ,Global
Founders Capital ,Global Sources ,Go Beyond Investing ,Greatbatch ,GT Healthcare ,Gustav Söderström ,Hampus Jakobsson ,Hanmi IT ,Harri Tilev ,Health Innovation Fund
,Health Innovations ,Henderson Land Development Company ,Herman Verrelst ,High-Tech Gründerfonds ,Hinduja Group ,Holland Venture ,Hoxton Ventures ,IDinvest
Partners ,imec ,Imperial Innovations ,Index Ventures ,Inge K. Hansen ,Initiative Capital Romandie ,INKEF Capital ,Innogest ,Innovacom ,Innovation Capital ,Innovationsstarter
Fonds ,Inserm Transfert Initiative ,Inven2 ,Inventure ,Inventures ,Invest4OncoDNA ,Invitalia Ventures ,IP Group ,IPF Partners ,IPG ,IQ Capital ,IRDInov ,Isabella Löwengrip
,Ixora Ventures ,Jaan Tallinn ,JamJar Investments ,Jan Schillebeeckx ,Johan Qviberg ,Joi Ito ,Jon Wright ,Jonas Nordlander ,Jonathan Milner ,K Fund ,Kainos ,Kaiser
Permanente Ventures ,Kapor Capital ,Karl-Georg Altenburg ,KCK ,Kernel Capital ,Khaled Helioui ,Kima Ventures ,Kinled Holding ,Kinnevik ,Korys ,Kryssen Capital ,KULeuven
,Kurma Partners ,Kustaa Piha ,L1 Capital ,Lagardère Active ,Länsförsäkringar ,LanzaTech Ventures ,Lars Forslund ,Laura Iris Ferro ,Laurent Alexandre ,Laurent Leksell ,LF Invest
,LGT Global Invest ,Life Sciences Partners ,LocalGlobe ,London Business Angels ,London Co Investment Fund ,LSIF ,LSP ,Luc Vauterin ,M Capital Partners ,Magnus Kjøller
,Malakoff Médéric ,Manuardeo ,Marc Beuls ,Marcos Val ,Matthias Hilpert ,MedTech Innovation Partners ,Medtronic ,Mérieux Développement ,Metsola Ventures
,MeusInvest ,Mittelständische Beteiligungsgesellschaft Sachsen ,Monkfish Equity ,Mosaic Ventures ,Müller Medien ,Mustafa Suleyman ,Nasdaq First North ,New Enterprise
Ventures ,NFT ventures ,Nick Robertson ,Noaber ,Nokia Growth Partners ,Nordea ,North West Fund ,NovioTech ,NSA Ventures ,Occident Group ,Octopus Ventures
40
2016 EUROPEAN HEALTHTECH REPORT INVESTORS CONT.
Oli Samwer ,Omnes Capital ,Ona Capital ,Oxford Capital ,Panakès Partners ,Par Equity ,Parana Management Corp ,Parkwalk Advisors ,Partech Ventures ,Passion Capital
,Perion Investment Fund ,Peter & Susanne Gjørup ,Peter Mellbye ,Peter Read ,PMV ,Polytech Ecosystem Ventures ,Project A Ventures ,Puhua Jingxin Guzhou Health
Management ,QBIC ,Reaktor Ventures ,Richard Reed ,Robin Batchelor ,Sam Altman ,Sambrinvest ,Samsung Ventures ,Scottish Investment Bank ,Sean Duffy ,SEB Alliance
,Seedcamp ,Seedrs ,Sensinnovat ,Sergio Dompé ,Seventure Partners ,SevenVentures ,Si14 ,Siparex Proximité Innovation ,Slack Fund ,Social Capital ,SOFI ,Sofia Levander
,Sofimac ,Sofinim ,Sophia Bendz ,SOSV ,SparkLabs Global Ventures ,SRIW ,STMicroelectronics ,Sunstone Capital ,Svein Aaser ,Sven Arild Andersen ,Swarraton Partners ,Swiss
Re ,Swisscom ,Target Global ,TechNano Fund ,Technology Venture Partners ,Tekes ,Telefónica Q-Growth ,The Chernin Group ,The Vandel Group ,Thomas Zeltner ,Thorleif
Enger ,Thuja Capital ,Tim Jackson ,TJP Consulting ,Tom Singh ,Topfonds Gelderland ,Torsten Osthus ,TQ-Group ,Udo Müller ,Unilever Ventures ,Union Square Ventures
,University of Bristol Enterprise Fund ,University of Cambridge Enterprise ,Van Herk Ventures ,VentureFounders ,Vinsovier ,Vitamina K ,W3 ,Wellington Partners ,White
Cloud Capital ,Woodford Investment Management ,Wren Capital ,Xavier Niel ,Xerys Gestion ,Yogen Dalal ,Ysios Capital ,ZKB
41
2016 EUROPEAN HEALTHTECH REPORT SCALEUPS
Abingdon Health, Acarix, Actronika, Aifloo, Alantaya, Aleva Neurotherapeutics, Arthro Therapeutics, AthGene, Ava Science, Babylon Health, Berlin Heals Holding, Big Health,
BioBeats, Biolog-ID, Biomodex, Biovotion, Blackford Analysis, Bloom Technologies, Blow, Bluebee, Brainshake, Bucmi, Cambridge Medical Robotics, CarThera, Cellink, Cera,
Cirdan, ClinicPoint, Clue, Coala Life, Creo Medical, Cunesoft, Cytomate Technologies, Devicare, D-Eye, Diasend, DocPlanner, Doctify, Doctor Anytime, Echo, Echolight,
Emperra, Enxray, EveryLIFE Technologies, Eyeco Eyeco, Famly, FineHeart, Fluidic Analytics, Foundry Innovation & Research 1 (Fire1), Frisq, Genesis, Glamma, G-Therapeutics,
H4D, HandInScan, Hapella, HealthUnlocked, Healx, HomeTouch, Horus Technology, i3 Membrane, Icometrix, Ignilife, Impulse Dynamics, Indigo Diabetes, Infinity Health,
Interaction Healthcare, Irras, Joy, Junomedical, KB Medical, Keranova, Kiweno, Kolibree, KRY, Kyomed, Lifesum, LifeTime, Listen, Live Better With, Mainstay Medical,
Massagio, MDLinking, Mdoloris, Medical Imaging Partnership, MedShr, MedUniverse, MesDocteurs, Micrima, microDimensions, Millidrop, Min Doktor, MindMaze, Mint
Solutions, Molecubes, MonDocteur, Movendo Technology, Natural Cycles, NetMedi, Network Locum, Newronika, NightBalance, Nino Robotics, Noona, NovioSense,
Numares, Nyxoah, OncoDNA, Oneview Healthcare, Ontoforce, Optics11, Otivio, Ōura, Owlstone Medical, Oxford Nanopore Technologies, Physidia, Popmyday, Promofarma,
Psyomics, Push Doctor, Qaelum, Qualison, Quantum Imaging, ReActive Robotics, Rythm, Salupro, Saphetor, Scandinavian Real Heart, Sekoia, Seven Bridges, SiriusXT, snap40,
Sonitor Technologies, Spectral Edge, Sphere Fluidics, SpineArt, STAT-Diagnostica, Surgivisio, T&J Healthcare, Teckro, The GP Service, Theraclion, Ugentec, UroMems,
Visiomed Group, Werlabs, Zilico
42
No dataset is complete and this report provides an indication of reality only. Comparing to
reports of other providers on similar subjects is partly possible when taking into account the
different methodologies.
This report has been compiled for informational purpose only and should not be regarded as a
solicitation to invest in any entity.
This report relies on data and insights from a wide range of public and private sources and we
can’t be hold responsible for the completeness and accuracy of the information provided.
This report may freely be distributed, republished and posted as long as the content is not
modified, decompiled or reference to the source is being removed.
2016 EUROPEAN HEALTHTECH REPORT DISCLAIMER